Public Company News
Recurrent Energy Signs 300 MW Power Purchase Agreement with Major U.S. Tech Company in Spain
KITCHENER, ON, Dec. 10, 2024 /PRNewswire/ -- Recurrent Energy
2024-12-10 20:00
2511
SurplusGLOBAL to Participate in SEMICON JAPAN 2024, Showcasing AI-Based 'SemiMarket' and Legacy Equipment Solutions
SEOUL, South Korea, Dec. 10, 2024 /PRNewswire/ -- SurplusGLOBAL will participate in SEMICONJAPAN 2024, scheduled to take place from December 11 to 13 at Tokyo Big Sight,Japan. With 1,182 companies from around the world set to join the exhibition, SurplusGLOBAL will be showcasing its legacy semico...
2024-12-10 20:00
2490
ChipMOS REPORTS 2.8% MoM INCREASE IN NOVEMBER 2024 REVENUE, DOWN 2.1% YoY
HSINCHU, Dec. 10, 2024 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC.
("ChipMOS" or the "Company") (Taiwan Stock Exchange:8150
2024-12-10 19:00
2443
Youdao 2024 Annual General Meeting of Shareholders
BEIJING, Dec. 10, 2024 /PRNewswire/ -- As announced on November 14, 2024, the Company is going to hold its annual general meeting of shareholders ("AGM") at itsBeijing offices on December 12, 2024 at 3:00 p.m. – 5:00 p.m. (Beijing Time). To watch the live broadcasting of the AGM, please click the...
2024-12-10 16:30
2406
Jinxin Technology Holding Company Announces Closing of US$5 Million Initial Public Offering
SHANGHAI, China, Dec. 9, 2024 /PRNewswire/ -- Jinxin Technology Holding Company (the "Company") (Nasdaq: NAMI), an innovative digital content service provider inChina, today announced the closing of its initial public offering (the "Offering") of 1,250,000 American Depositary Shares ("ADSs") at a...
2024-12-10 12:00
2522
Lunit Marks Go-Live in Groundbreaking National AI Cancer Screening Program in BreastScreen NSW
Lunit INSIGHT MMG integrated into the clinical workflow of Australia's BreastScreen New South Wales to assist in reading approximately 31,000 mammography exams annually SEOUL, South Korea, Dec. 9, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer d...
2024-12-09 22:00
2899
Taoping Signs Non-binding Letter of Intent to Acquire Yunti; Transformational Acquisition Would Substantially Improve Taoping's Annual Revenue, Expand its Addressable Market, and Leverage its Current Portfolio
SHENZHEN, China, Dec. 9, 2024 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company"), a provider of innovative smart cloud platform services and solutions, new media and artificial intelligence (AI) solutions, today announced that it has signed a non-binding letter of intent to acquire 100% o...
2024-12-09 21:30
3553
Actinogen randomizes first US participant in XanaMIA phase 2b/3 Alzheimer's disease trial
* Late-stage trial in Alzheimer's opens 10 sites in US, with results due in 2025 and 2026 * Appoints US-based Chief Commercial Officer, Andrew Udell * Xanamem's unique ability to control brain cortisol draws widespread coverage in the Australian media. SYDNEY, Dec. 9, 2024 /PRNewswire/ -- A...
2024-12-09 21:00
2939
Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate
BEIJING, Dec. 9, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced that the National Medical Products Administration of...
2024-12-09 20:30
2899
Noah Showcases Global Expansion and Investment Product Leadership at 2024 Corporate Open Day
* Accelerating global expansion into emerging markets with new brands * Global investment allocation strategies and expanded product offerings drive long-term value for clients * Expanding comprehensive service matrix to address evolving client needs globally SHANGHAI, Dec. 9, 2024 /PRNewswi...
2024-12-09 19:00
3118
Dizal Presents Latest Data of DZD8586, a LYN/BTK Dual Inhibitor, in B-cell Non-Hodgkin Lymphoma at the 2024 ASH Annual Meeting
DZD8586 demonstrated encouraging anti-tumor activity with manageable safety and favorable pharmacokinetic (PK) characteristics in patients with B-NHL SHANGHAI, Dec. 9, 2024 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment o...
2024-12-09 18:00
2287
iQIYI Introduces 'Extra Large Font' Function to Enhance Accessibility for Senior Users
BEIJING, Dec. 9, 2024 /PRNewswire/ -- iQIYI, China's leading online entertainment platform, recently launched a new 'Extra Large Font' function on its app, offering a comprehensive suite of accessibility features tailored for senior users and the visual requirements of a broader audience. With ju...
2024-12-09 17:05
2898
Acer Announces November Revenues at NT$22.75 Billion, Up 20.9% Month-on-month and 13.1% Year-on-year
TAIPEI, Dec. 9, 2024 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its consolidated revenues for November atNT$22.75 billion with 20.9% growth month-on-month and 13.1% growth year-on-year (YoY). Consolidated revenues for year-to-November revenues reachedNT$240.16 billion with 10.4% growth YoY....
2024-12-09 16:44
2254
Hello Group Inc. Announces Unaudited Financial Results for the Third Quarter of 2024
BEIJING, Dec. 9, 2024 /PRNewswire/ -- Hello Group Inc. (NASDAQ: MOMO) ("Hello Group" or the "Company"), a leading player in mainlandChina's online social networking space, today announced its unaudited financial results for the third quarter of 2024. Third Quarter of 2024 Highlights * Net r...
2024-12-09 16:16
2689
2024 ASH Oral Presentation----Abbisko presents promising preliminary phase 2 study results of pimicotinib in the treatment of Chronic Graft-versus-Host Disease (cGvHD) at the 66th ASH Annual Meeting
SHANGHAI, Dec. 8, 2024 /PRNewswire/ -- December 8, 2024, Abbisko Therapeutics (HKEX: 02256) announced the presentation of preliminary Phase 2 study results for pimicotinib (ABSK021) in patients with chronic Graft-versus-Host Disease (cGvHD) who have either progressed or not responded to one or mo...
2024-12-09 10:40
2414
Jacobio Pharma Presented preliminary Data on BET Inhibitor for Myelofibrosis at 2024 ASH
BEIJING, SHANGHAI and BOSTON, Dec. 8, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company dedicated to developing therapies toward undruggable targets, today presented preliminary Phase I data of BET inhibitor JAB-8263 to treat myelofibrosis (MF) at the 2024 ASH (Ame...
2024-12-09 08:42
2184
Caliway Biopharmaceuticals Included in FTSE TWSE Taiwan Eight Industries and Mid-Cap 100 Indices
NEW TAIPEI CITY, Dec. 6, 2024 /PRNewswire/ -- Caliway Biopharmaceuticals Co., Ltd. (TWSE-6919) is proud to announce its inclusion in the FTSE TWSE Taiwan Mid-Cap 100 Index and the FTSE TWSE Taiwan Eight Industries Index, two prestigious benchmarks jointly compiled by FTSE Russell and the Taiwan S...
2024-12-07 08:57
4374
Baijiayun Announces Up To $15 Million Convertible Promissory Notes And $50 Million Standby Equity Purchase Agreement
BEIJING, Dec. 6, 2024 /PRNewswire/ -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ: RTC), a one-stop AI video solution provider, today announced that it has entered into a Standby Equity Purchase Agreement (the "SEPA"), with YA II PN, Ltd. ("YA"), a fund managed by Yorkville Advisor...
2024-12-07 06:00
17459
JXJT First Half Year Financial Report 2024: Achieved 30% Revenue Surge and Strong Profit Growth
HAIKOU, China, Dec. 6, 2024 /PRNewswire/ -- JX Luxventure Limited (Nasdaq: JXJT) (the "Company"), a technology company engages in integrated tourism services, including tourism, duty-free cross-border goods, and comprehensive e-commerce technology solutions, today announced financial results for ...
2024-12-06 22:28
5483
Marvion Inc. Announces Application Submission to Quote on OTCQB® Venture Market Providing Direct Path to Liquidity for Investors
HONG KONG, Dec. 6, 2024 /PRNewswire/ -- Marvion Inc. (OTC: MVNC), a logistics and storage services company dedicated to deliver one stop logistics, storage and distribution services to B2B customers inHong Kong such as FedEx, SF Express, etc, today announced that it has submitted the necessary ap...
2024-12-06 21:08
4799
Week's Top Stories
Most Reposted
Visa Destinations Launches in Asia Pacific as Regional Travel Remains Resilient
[Picked up by 331 media titles]
2026-05-05 10:01Agoda Makes it Easier for Travelers to See Relevant Photos in Reviews
[Picked up by 313 media titles]
2026-05-06 12:00
AVPN AI Opportunity Fund Expands to Build AI-Ready Generations Across Asia by Empowering Educators and Youth Across Asia-Pacific
[Picked up by 298 media titles]
2026-05-05 09:00Visa amps up the music as Official Payment Partner for the Asia leg of The Weeknd's 'After Hours Til Dawn' Stadium Tour
[Picked up by 293 media titles]
2026-05-11 16:20
Colebrook Bosson Saunders Expands Flo X Multi Compatibility for Curved Ultrawide Monitors
[Picked up by 290 media titles]
2026-05-05 11:00
Most Read
Visa Destinations Launches in Asia Pacific as Regional Travel Remains Resilient
2026-05-05 10:01
8179
Amadeus delivers solid Q1 2026 growth, and maintains commercial momentum
2026-05-08 18:30
7503
Massimo Group Launches Sentinel 770 HVAC as Part of Sentinel Product Line Targeting Approximately US$10 Million in 2026 Revenue
2026-05-06 21:20
7035
LightInTheBox to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026
2026-05-06 20:00
6995
